Shiao-pei S. Weathers

Neurology

1515 Holcombe Blvd
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 07, 2026

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 14, 2026

Perioperative neurocognitive functioning in elderly patients undergoing awake craniotomy for high grade glioma.

Perioperative neurocognitive functioning in elderly patients undergoing awake craniotomy for high grade glioma.

Journal: Neuro-oncology advances

Published: August 09, 2025

CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.

CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.

Journal: Neuro-oncology advances

Published: August 04, 2025

High-grade glioma with pleomorphic and pseudopapillary features: a single-institution series of three cases.

High-grade glioma with pleomorphic and pseudopapillary features: a single-institution series of three cases.

Journal: Acta neuropathologica communications

Published: May 28, 2025

Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastoma.

Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastoma.

Journal: Journal of neuro-oncology

Published: May 12, 2025

Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses : Treatment intensification, margin reduction and epigenetic stratified outcomes with radiation therapy and chemotherapy.

Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses : Treatment intensification, margin reduction and epigenetic stratified outcomes with radiation therapy and chemotherapy.

Journal: Journal of neuro-oncology

Published: May 05, 2025

Glioblastoma in young adult patients: contemporary patterns of care and survival in the United States.

Glioblastoma in young adult patients: contemporary patterns of care and survival in the United States.

Journal: Journal of neuro-oncology

Published: May 01, 2025

Clinical and Imaging Features of Primary Intradural Extramedullary Ewing Sarcoma.

Clinical and Imaging Features of Primary Intradural Extramedullary Ewing Sarcoma.

Journal: AJNR. American journal of neuroradiology

Published: April 14, 2025

Simulation-based caregiving skills training for family members of high-grade glioma patients.

Simulation-based caregiving skills training for family members of high-grade glioma patients.

Journal: Neuro-oncology practice

Published: July 15, 2024

Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case-control study.

Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case-control study.

Journal: Neuro-oncology practice

Published: July 15, 2024

Perspectives from neuro-oncology providers on patient access to electronic records: a survey study.

Perspectives from neuro-oncology providers on patient access to electronic records: a survey study.

Journal: CNS oncology

Published: June 13, 2024

Showing 1-12 of 60

Last Updated: 09/26/2026